Using Artificial Intelligence to Fight Multiple Myeloma
Can Donating Platelets Save a Cancer Patient's Life?
FDA Places Keytruda Multiple Myeloma Studies on Hold
Generic Drugs for Multiple Myeloma: Biosimilars
EHA 2017: Newly Diagnosed Myeloma
EHA 2017: The Art of Treating Multiple Myeloma
Summer Fun and Safety for Cancer Patients
Medicare and the Cost of Multiple Myeloma Drugs
A Cancer Caregiver's Open Letter to Family and Friends: Please Understand, Life After Cancer is Different
ASCO 2017: CAR T Cell Therapy Shows Incredible Results in Myeloma
How To Pick A Multiple Myeloma Doctor
Why Does Chemo Cause Hair Loss?
Living Long-Term With Myeloma - Part 2: Renal Function
Fighting Cancer Is Hard. 15 Tips for Living With Chronic Illness
Myeloma Crowd Research Initiative (MCRI) Funds Two Immunotherapy Projects
Continuing the Fight for a Myeloma Cure: Dr. Tricot and Dr. Zhan's Research to Improve Outcomes for High-Risk Myeloma Patients
New Bi-Specific Antibody Hitting Two Targets in Myeloma, Dirk Hose, MD and Anja Seckinger, MD, University of Heidelberg
Dr. Dirk Hose & Dr. Anja Seckinger are working on a new bi-specific antibody that joins a powerful myeloma-killing T cell with the target BCMA
Is There one Sugar That is Better (or less bad) Than Others for Cancer Patients?
Clinical Trial: FDA Approved Drugs in Other Cancers (Dabrafenib/Trametinib) Now Used In Early Myeloma Clinical Trial for Relapsed/Refractory Patients
Relapse of Multiple Myeloma: What Happens Next?
Normalcy and Myeloma Remission
Curcumin Gets Positive Results in Small MGUS and Smoldering Study
How to Cope With a Parent Who Has Cancer
New Drug GMI-1271 May Help Velcade Work Again in Relapsed Myeloma
